
    
      This is a Phase 1, double-blind, randomized (participants taste the same groups of drugs
      [formulations] but in random order), single-center trial in healthy adult participants. The
      study will include 2 Sessions of 1 day, 1) Session 1, in which participants will receive 6
      JNJ-53718678 oral solutions (1 reference and 5 different formulations) sequentially in a
      randomized order, Scoring of the taste will be done via a questionnaire designed for this
      purpose; 2) Session 2, within approximately a timeframe of 7 to 14 days after completion of
      Session 1, participants will taste 2 best scoring tastes coming out of Session 1. The study
      will consist of a screening phase of approximately 2 weeks, treatment phase of approximately
      2 weeks and a post-treatment follow-up phase of 10 days after completion of the last Session.
      The total study duration for each participant will be approximately 6 weeks.
    
  